The BGTC knows the current number of therapies for rare diseases just isn’t good enough. We are pleased to announce our clinical trial portfolio, aiming to make gene therapies more accessible and sustainable no matter the size of the patient population. https://t.co/IBcGKy2LeO
#BGTC is proud to observe #RareDiseaseDay 2023 with “Taylor’s Story.” Watch the full film highlighting the patient perspective and underscoring our commitment to accelerate therapies for ultra-rare diseases: https://t.co/y6S8wxXCOj
#RareDisease#RDDNIH#ShowYourStripes
FNIH co-funded a recent multinational trial showing that a low-cost, single-dose antibiotic can reduce the risk of life-threatening sepsis in women giving birth. The trial results have the potential to significantly improve maternal health worldwide: https://t.co/LcvTZxx2RP
Thankful for the engaging evening we had for the #FNIHAwardsCeremony as we gathered with people who are fundamental to moving our work forward to honor some truly phenomenal scientists and partners.
Julie Gerberding, along with Dr. @VasNarasimhan of @Novartis will be the featured speaker at the Georgia’s Center for Global Health Innovation’s annual Bio Innovation Summit on Tuesday, October 11. Learn more and register here: https://t.co/Db2ppAZdyD
This #WorldHeartDay, we are proud to announce our partnership with @FNIH_Org and @nih_nhlbi, in the AMP® Heart Failure initiative.
Together we aim to alter the landscape of heart failure detection & treatment, improving the lives of millions.
Read more: https://t.co/4hsZIIxe2D
To celebrate #WorldHeartDay, the Foundation for the National Institutes of Health @FNIH_Org announces a new collaborative partnership to deconstruct the syndrome of heart failure with preserved ejection fraction (HFpEF). Learn more: https://t.co/k2Bu5AHHod
A big news day here, and a bit of a full circle moment for me as well. Looking forward to working together to advance research that saves lives and improves health.
The FNIH is proud to announce Dr. Julie Gerberding, renowned health advocate, leader at @Merck and @CDCgov and infectious disease expert at @UCSF will start on May 16 as its next CEO and lead the way in advancing biomedical research.
Learn more: https://t.co/m7jBFNcugx
They say you should never meet your heroes, but with the news of the devastating loss of #PaulFarmer this week, I’m so proud that I can say he exceeded every expectation. While his loss is immense to #globalhealth, his legacy are the generations of health workers he inspired.
The NIMBLE project is featured in a new publication in @Nature Medicine! Spearheaded by the FNIH, the project convenes partners to identify non-invasive methods of diagnosing and assessing disease progression in non-alcoholic steatohepatitis (NASH).
Read: https://t.co/Jjh1pgGoSS
The FNIH is dressed for #WearRedDay in honor of heart health! Today, wear red to raise awareness around heart disease.
Check out social media resources, fact sheets, and posters from @nih_nhlbi you can use to educate yourself and your community: https://t.co/t00PWrdzXv
“Health equity is not only accessible healthcare for patients, but developing educational and professional opportunities to create a diverse pipeline of educators, clinicians and other professionals, as well as ensuring all are included in clinical studies,” said @MSMPres
Novartis Pledges 10-year Commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other Leading Organizations to Co-Create Effective, Measurable Solutions for Health Equity: https://t.co/ncElOkH7Jq
Grateful for the efforts of everyone who has been involved in bringing this partnership to launch, and incredibly excited for the path to progress we are charting at @MSMEDU
Novartis and the Novartis US Foundation announce a 10-year commitment with Historically Black Colleges, Universities, Medical Schools & other organizations to co-create effective, measurable solutions for health equity in the US. #NovartisNews
To understand the entirety of the human condition & develop specialized, cost-effective health care, research must include Black patients.
MSM has the capability & track record to diversify clinical trials & improve outcomes for everyone.
To donate: https://t.co/vn00S8hxqI
This story does an excellent job of illustrating the barriers that have created and exacerbated health disparities in rural communities long before the challenges of COVID-19. Successful vaccination depends on trusted partners in the community. https://t.co/HIf3SkcZlB
It will remain one of the great privileges of my career to have known and worked with Anne Schuchat, someone who epitomizes a quiet and steadfast dedication to public service and public health. What I Learned in 33 Years at the C.D.C. https://t.co/LN7WrgMJxV